1
Gale Eugene Smith, Franklin Volvovitz, Bethanie Eident Wilkinson, Craig Stanway Hackett: Method for producing influenza hemagglutinin multivalent vaccines using baculovirus. MG PMC, Thomas J Kowalski, Curtis Morris & Safford PC, June 9, 1998: US05762939 (83 worldwide citation)

A method of preparing a recombinant influenza vaccine using DNA technology is provided. The resulting vaccine is a trivalent influenza vaccine based on a mixture of recombinant hemagglutinin antigens cloned from influenza viruses having epidemic potential. The recombinant hemagglutinin antigens are ...


2
Gale E Smith, Franklin Volvovitz, Bethanie E Wilkinson, Andrei I Voznesensky, Craig S Hackett: Method for producing influenza hemagglutinin multivalent vaccines. Protein Sciences Corporation, Thomas J Kowalski, Frommer Lawrence & Haug, June 12, 2001: US06245532 (24 worldwide citation)

A method of preparing a recombinant influenza vaccine using DNA technology is provided. The resulting vaccine is a multivalent, preferably trivalent, influenza vaccine based on a mixture of recombinant hemagglutinin antigens cloned from influenza viruses having epidemic potential. The recombinant he ...


3
Smith Gale Eugene, Volvovitz Franklin, Wilkinson Bethanie E, Voznesensky Andrei I, Hackett Craig Stanway: A method for producing influenza hemagglutinin multivalent vaccines. Mg Pmc, December 14, 2005: EP1605052-A2 (2 worldwide citation)

A method of preparing a recombinant influenza vaccine using DNA technology is provided. The resulting vaccine is a multivalent, preferably trivalent, influenza vaccine based on a mixture of recombinant hemagglutinin antigens cloned from influenza viruses having epidemic potential. The recombinant he ...


4
Smith Gale Eugene, Volvovitz Franklin, Wilkinson Bethanie E, Voznesensky Andrei I, Hackett Craig Stanway: A method for producing influenza hemagglutinin multivalent vaccines. Mg Pmc, January 15, 2003: EP1275726-A2

A method of preparing a recombinant influenza vaccine using DNA technology is provided. The resulting vaccine is a multivalent, preferably trivalent, influenza vaccine based on a mixture of recombinant hemagglutinin antigens cloned from influenza viruses having epidemic potential. The recombinant he ...


5

6
G E Smith, F Volvovitz, B E Wilkinson: Method for producing influenza hemagglutinin multivalent vaccines. Mg Pmc, L L C, luo hong, September 23, 1998: CN95197928

A method of preparing a recombinant influenza vaccine using DNA technology is provided. The resulting vaccine is a multivalent, preferably trivalent, influenza vaccine based on a mixture of recombinant hemagglutinin antigens cloned from influenza viruses having epidemic potential. The recombinant he ...


7
SMITH GALE EUGENE, VOLVOVITZ FRANKLIN, WILKINSON BETHANIE E, VOZNESENSKY ANDREI I, HACKETT CRAIG STANWAY: A method for producing influenza hemagglutinin multivalent vaccines, Verfahren zum Herstellen von hämaglutinin-multivalenten Influenza-Impfstoffen, Procédé pour la production de vaccins polyvalents contre lhémagglutinine de la grippe. PROTEIN SCIENCES, October 12, 2011: EP2374894-A2

A method of preparing a recombinant influenza vaccine using DNA technology is provided. The resulting vaccine is a multivalent, preferably trivalent, influenza vaccine based on a mixture of recombinant hemagglutinin antigens cloned from influenza viruses having epidemic potential. The recombinant he ...


8
Smith Gale Eugene, Volvovitz Franklin, Wilkinson Bethanie E, Voznesensky Andrei I, Hackett Craig Stanway: A method for producing influenza hemagglutinin multivalent vaccines. Mg Pmc, KOWALSKI Thomas J, November 28, 1996: WO/1996/037624

A method of preparing a recombinant influenza vaccine using DNA technology is provided. The resulting vaccine is a multivalent, preferably trivalent, influenza vaccine based on a mixture of recombinant hemagglutinin antigens cloned from influenza viruses having epidemic potential. The recombinant he ...


9

10


Click the thumbnails below to visualize the patent trend.